Skip to Content
Merck
All Photos(3)

Documents

MABF925

Sigma-Aldrich

Anti-FcγRII (human) Antibody, clone AT10

clone AT10, from mouse

Synonym(s):

CD32CDw32, Fc-gamma RII-a, Fc-gamma RII-b, Fc-gamma RII-c, Fc-gamma-RIIa, Fc-gamma-RIIb, Fc-gamma-RIIc, FcRII-a, FcRII-b, FcRII-c, IgG Fc receptor II-a, IgG Fc receptor II-b, IgG Fc receptor II-c, Low affinity immunoglobulin gamma Fc region receptor II-a

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

mouse

Quality Level

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

AT10, monoclonal

species reactivity

human

technique(s)

flow cytometry: suitable

isotype

IgG1κ

UniProt accession no.

shipped in

dry ice

target post-translational modification

unmodified

Gene Information

General description

FcγRI/CD64, FcγRII/CD32, FcγRIII/CD16, and FcγRIV/CD16-2 represent the four known classes of IgG Fc receptors (FcγRs). FcγRII, FcγRIII, and FcγRIV are low-affinity receptors for monomeric IgG, whereas FcγRI is the only high-affinity FcγR. FcγRs play important roles in inflammatory cell activation, clearance, presentation of Ag, and maintenance of IgG homeostasis. In addition to binding immune complex (IC), FcγRs have been shown to bind non-IgG ligands. For example, FcγRII is shown to bind oxLDL, while FcγRIII binding to an E. coli component is reported to negatively regulate the function of macrophage receptor with collagenous structure (MARCO). FcyRII activation is also reported to transduce a negative regulatory signal against CD38 crosslinking-induced proliferation of resting mature B cells. Low affinity immunoglobulin gamma Fc region receptor II-a/b/c (IgG Fc receptor II-a/-b/-c, CDw32, Fc-gamma RII-a/-b/-c, Fc-gamma-RIIa/b/c, FcRII-a/-b/-c, CD32) are encoded by the FCGR2A/B/C (CD32, FCG2, IGFR2) genes in human (UniProt P12318, P31994, P31995; Gene ID 2212, 2213, 9103). The FcγRIIs encoded by the three genes are highly conserved in their extracellular portion, with significant variation in the transmembrane and intracellular regions. All three types of transcripts alternative splicing to generate additional isoforms.

Specificity

Clone AT10 targets the extracellular domain of human FcγRII and blocks its Fc binding activity. Expected to bind all three human FCGR2 genes-encoded FcγRII spliced isoforms reported by UniProt (P12318, P31994 & P31995).

Immunogen

Epitope: Extracellular domain.
Human erythroleukaemic K562 cells.

Application

Anti-FcγRII (human) Antibody, clone AT10 is an antibody against FcγRII for use in Flow Cytometry.
Flow Cytometry Analysis: 25 µg/mL from a representative lot was conjugated with FITC and detected FcγRII surface expression among the monocytes, but not the lymphocytes population of human peripheral blood mononuclear cells (PBMCs) by flow cytometry (Courtesy of Professor Martin J. Glennie, University of Southampton, UK).
Flow Cytometry Analysis: A representative lot was conjugated with Phycoerythrin (PE) and immunostained the surface of human Burkitt′s lymphoma Ramos cells transfected with FcγRIIB, but not untransfected Ramos cells (Courtesy of Professor Martin J. Glennie, University of Southampton, UK).
Flow Cytometry Analysis: Clone AT10 hybridoma culture supernatant was employed to detect FcγRII-positive peripheral blood lymphocytes (PBLs) by flow cytometry (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Immunoprecipitation Analysis: A representative lot immunoprecipitated FcγRII from human K562 erythroleukemic cells (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Affinity Binding Assay: Affinity binding study using the Fab′ fragment of clone AT10 showed an equilibrium binding constant (Ka) of 5.3 x 10^8/M and a total of 1.5 x 10^5 binding sites per K562 cell (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Neutralization Analysis: The F(ab′)2 fragment of clone AT10 blocked FcγRII-dependent B-cell activation by a chimeric anti-CD40 mAb with human IgG1 Fc (ChiLob 7/4 h1) induced in the presence of FcγRII-overexpressing 293F as the crosslinking cells (White, A.L., et al. (2015). Cancer Cell 27(1):138–148).
Neutralization Analysis: Both the Fab′ and F(ab′)2 fragments of clone AT10, but not control IgG1 or control F(ab′)2, blocked K562 cells from rosetting with rabbit IgG-coated chick red blood cells (CRBCs) (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Neutralization Analysis: The F(ab′)2 fragment of clone AT10 blocked the lysis of chick red blood cells (CRBCs) by effector cells via redirected cellular cytotoxicity (RCC; antibody-dependent cell-mediated cytolysis; ADCC) mediated by an anti-CRBC monoclonal antibody (E11C12) (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Research Category
Inflammation & Immunology
Research Sub Category
Immunoglobulins & Immunology

Quality

Evaluated by Flow Cytometry analysis of human PBMCs.

Flow Cytometry Analysis: 1.0 µg of this antibody detected FcγRII in 1x10E6 human peripheral blood mononuclear cells (PBMCs).

Target description

31.30 kDa (FcγRIIA), 29.49 kDa (FcγRIIB1), 27.39 kDa (FcγRIIB2), 29.22 kDa (FcγRIIB3), 31.03 kDa (FcγRIIC1), 25.69 kDa (FcγRIIC2), 24.82 kDa (FcγRIIC3), 21.35 kDa (FcγRIIC4) calculated. ~42 kDa (glycosylated) and ~36 kDa (PNGase F treated) reported (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).

Physical form

Format: Purified
Protein G Purified
Purified mouse monoclonal IgG1κ antibody in PBS without preservatives.

Storage and Stability

Stable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

Other Notes

Concentration: Please refer to lot specific datasheet.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Valter R M Lombardi et al.
Experimental and therapeutic medicine, 15(3), 2547-2556 (2018-02-23)
Novel effective chemopreventive agents against cancer are required to improve current therapeutic rates. The aim of the present study was to investigate the anti-carcinogenesis effect of AntiGan, an extract obtained from the European conger eel, Conger conger, in vitro (human
Aurore Morello et al.
PloS one, 8(8), e73375-e73375 (2013-08-31)
Membrane FasL is the natural trigger of Fas-mediated apoptosis. A soluble homotrimeric counterpart (sFasL) also exists which is very weakly active, and needs oligomerization beyond its trimeric state to induce apoptosis. We recently generated a soluble FasL chimera by fusing
Andrea Doni et al.
Nature communications, 12(1), 3739-3739 (2021-06-20)
Serum amyloid P component (SAP, also known as Pentraxin 2; APCS gene) is a component of the humoral arm of innate immunity involved in resistance to bacterial infection and regulation of tissue remodeling. Here we investigate the role of SAP

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service